Statement Of Financial Position [Abstract]

Egetis Therapeutics - Filing #676549

Concept	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Right-of-use assets	—	—	—	43,000,000 SEK	—	26,000,000 SEK	—	—	—	—	—	—	—	—	—
Other non-current financial assets	—	—	—	8,000,000 SEK	—	8,000,000 SEK	—	—	—	—	—	—	—	—	—
Non-current assets	—	—	—	4,143,000,000 SEK	—	4,137,000,000 SEK	—	—	—	—	—	—	—	—	—
Current assets [abstract]
Current inventories	—	—	—	7,000,000 SEK	—	6,000,000 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	3,033,000,000 SEK	—	1,277,000,000 SEK	—	—	—	—	1,440,000,000 SEK	—	—	—	—
Current assets	—	—	—	3,459,000,000 SEK	—	1,474,000,000 SEK	—	—	—	—	—	—	—	—	—
Assets	—	—	—	7,602,000,000 SEK	—	5,611,000,000 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	154,000,000 SEK	—	113,000,000 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	—	—	—	1 266,5 SEK	—	9,396,000,000 SEK	—	—	—	—	—	—	—	—	—
Other reserves	—	—	—	167,000,000 SEK	—	61,000,000 SEK	—	—	—	—	—	—	—	—	—
Equity	154,000,000 SEK	1 266,5 SEK	1 780,0 SEK	5,456,000,000 SEK	167,000,000 SEK	5,062,000,000 SEK	9,396,000,000 SEK	113,000,000 SEK	61,000,000 SEK	1 428,4 SEK	5,270,000,000 SEK	7,458,000,000 SEK	13,000,000 SEK	1 262,8 SEK	87,000,000 SEK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	—	—	—	1,108,000,000 SEK	—	55,000,000 SEK	—	—	—	—	—	—	—	—	—
Current liabilities [abstract]
Current tax liabilities, current	—	—	—	1,000,000 SEK	—	- SEK	—	—	—	—	—	—	—	—	—
Current liabilities	—	—	—	1,039,000,000 SEK	—	494,000,000 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities	—	—	—	7,602,000,000 SEK	—	5,611,000,000 SEK	—	—	—	—	—	—	—	—	—